Showing results (121-130 of 195) with videos related to
Sort By:
Pageof 20
Cancer Research|September 24, 2009
Expression of IFN-beta enhances both efficacy and safety of oncolytic vesicular stomatitis virus for therapy of mesotheliomaCandice L Willmon, Vassiliki Saloura, Zvi G Fridlender, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2017
Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment EfficacyKevin G Shim, Shane Zaidi, Jill Thompson, et al.Journal for Immunotherapy of Cancer|July 19, 2019
Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicityMatthew R Schuelke, Phonphimon Wongthida, Jill Thompson, et al.Cancer Research|December 20, 2007
Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancerTimothy Kottke, Luis Sanchez-Perez, Rosa Maria Diaz, et al.Agricultural and Forest Entomology|March 22, 2024
Silvopastoral systems benefit invertebrate biodiversity on tropical livestock farms in Caquetá, ColombiaLois Kinneen, María Paula Escobar, Luis Miguel Hernandez, et al.The Journal of Clinical Investigation|April 6, 2010
Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in miceTimothy Kottke, Geoff Hall, Jose Pulido, et al.Experimental Cell Research|May 1, 2007
The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat modelNicolas Larmonier, Dominique Cathelin, Claire Larmonier, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2020
Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell ResponsesAmanda L Huff, Laura Evgin, Jill Thompson, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2015
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune ResponsesKarishma Rajani, Christopher Parrish, Timothy Kottke, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 28, 2011
Precise scheduling of chemotherapy primes VEGF-producing tumors for successful systemic oncolytic virotherapyTimothy Kottke, John Chester, Elizabeth Ilett, et al.Pageof 20